Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Response to supraphysiological testosterone is predicted by a distinct AR cistrome [ChIP-seq]

ABSTRACT: Response to supraphysiological testosterone is predicted by a distinct AR cistrome [ChIP-seq]

PROVIDER: PRJNA777879 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16771743_1.fastq.gz	Fastqsanger.gz
	SRR16771743_2.fastq.gz	Fastqsanger.gz
	SRR16771744_1.fastq.gz	Fastqsanger.gz
	SRR16771744_2.fastq.gz	Fastqsanger.gz
	SRR16771745_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 92

Similar Datasets

Response to supraphysiological testosterone is predicted by a distinct AR cistrome

Project description:Response to supraphysiological testosterone is predicted by a distinct AR cistrome

| PRJNA777873 | ENA

Response to supraphysiological testosterone is predicted by a distinct AR cistrome [RNA-seq]

Project description:Response to supraphysiological testosterone is predicted by a distinct AR cistrome [RNA-seq]

| PRJNA777878 | ENA

Response to supraphysiological testosterone is predicted by a distinct AR cistrome

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-04-06 | GSE188176 | GEO

Response to supraphysiological testosterone is predicted by a distinct AR cistrome [RNA-seq]

Project description:We generated RNA-Seq in CRPC PDX with SPT treatment

2022-04-06 | GSE188174 | GEO

Response to supraphysiological testosterone is predicted by a distinct AR cistrome [ChIP-seq]

Project description:We generated transcription factor, histone modification ChIP-Seq in CRPC PDX with SPT treatment

2022-04-06 | GSE188173 | GEO

Cistrome analyses of AR-V7.

Project description:Cistrome analyses of AR-V7.

| PRJNA913106 | ENA

Cistrome analyses of AR stimulated by 0.1 nM DHT in LNCaP stable cell line overexpressing AR [ChIP-Seq]

Project description:The molecular drivers for the AR signaling reprogramming in castration-resistant prostate cancer remain to be determined. In this study, we hypothesize that increased AR expression in conjunction with lower-level androgens, which is a typical condition in prostate cancer cells receiving androgen deprivation therapy, is a major driving force of the reprogramming. To test this, we used LNCaP model with inducible overexpression of AR to examine the acute effects of AR overexpression stimulated by low-dose DHT (0.1nM) on AR cistrome.

2022-11-21 | GSE211639 | GEO

Characterization of the AR cistrome in ER-negative breast cancer cell lines

Project description:Although molecular apocrine and some triple negative breast cancer tumours express high levels of AR, how AR signalling impacts their proliferative rate remains an area of controversy. The precise molecular mechanisms by which the AR can induce divergent proliferative effects in estrogen receptor-negative breast cancers has not been described. The potent androgen, DHT, inhibits proliferation of the MFM-223 estrogen receptor-negative breast cancer cell line. In contrast, activation of the AR by DHT either stimulates, or has no effect, on MDA-MB-453 cell proliferation. The AR cistrome was examined in order to identify candidate factors which mediate oncogenic versus tumour suppressive AR activity in ER-negative breast cancer.

2024-10-28 | GSE186873 | GEO

RNA-sequence on kidneys of wild type C57BL/6J and ARLmon/Y mice that underwent orchidectomy and testosterone (or vehicle) replacement for 4 days

Project description:We generated a mouse model (ARLmon/Y) with disrupted dimerization of the ligand-binding domain 25 (LBD) of the androgen receptor (AR). These mice exhibit an external female phenotype with undescended testes. Histological analysis of the testes of ARLmon/Y mice revealed some residual spermatogenesis. Hormone measurements in serum of the ARLmon/Y mice showed significantly high levels of androgens. To study if there is any remaining AR activity, we orchidectomized WT and ARLmon/Y mice and gave them supraphysiological testosterone replacement for 4 days. RNA-seq was performed on kindeys.

2021-08-23 | GSE172020 | GEO

Cistrome analyses of AR-V7.

Project description:Although AR-V7 has been intensively studied, it remains unclear whether AR-V7 can specifically activate a distinctive transcriptional program from the full-length AR (AR-FL), and whether AR-V7 may play a role in accelerating the metastatic progression of castration-resistant PCa (CRPC). In this study, we hypothesize that AR-V7 can drive a distinct transcription program from AR-FL in CRPC condition. To test this, we used LNCaP model with inducible overexpression of AR-V7 or AR-FL to examine the effects of AR-V7 overexpression or AR-FL overexpression stimulated with DHT for 4 hours on AR-V7 or AR-FL cistromes. We also studied the effects of AR-V7 on cistromes of pioneer factor FOXA1 and active histone marker H3K27ac, and the function of phosphorylation at Ser81 on AR-V7 function in CRPC.

2024-06-05 | GSE221140 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data